DynaChip X1 Platform Commercialization

About Andson Biotech

Andson Biotech is a private, pre-revenue platform company founded in 2016 and headquartered in Atlanta, Georgia (with a noted presence in San Diego). The company has developed the DynaChip X1, a benchtop instrument that leverages breakthrough microfluidic chip technology to automate and streamline sample preparation for mass spectrometry. This platform targets critical bottlenecks in the characterization of advanced biotherapeutics like monoclonal antibodies, ADCs, and AAVs, aiming to improve throughput, consistency, and data quality for biopharma R&D. Led by CEO and co-founder Dr. Mason Chilmonczyk, the company is backed by a board with industry and academic expertise and is focused on commercializing its tool to broaden access to high-end mass spec analysis.